Skip to content
XSNX 0.01 0.00 -17.36%
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Menu
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
XSNX 0.01 0.00 -17.36%
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Menu
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Day:
April 30, 2024
NovAccess Global Announces New License to Advance its Immunotherapy Platform